The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody

被引:0
|
作者
Daniela Tudor
Anne-Sophie Drillet
Isabelle Schwartz-Cornil
Ruizhong Shen
Phillip D Smith
Morgane Bomsel
机构
[1] Institut Cochin,
[2] INRA,undefined
[3] University of Birmingham,undefined
来源
关键词
Neutralize Activity; ADCC Activity; Membrane Proximal Region; Heavy Chain Constant Region; Envelope Transmembrane;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies
    Dezhi Li
    Jie Liu
    Li Zhang
    Tianshu Xu
    Junheng Chen
    Liping Wang
    Qi Zhao
    Virologica Sinica, 2015, 30 (06) : 449 - 456
  • [42] N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies
    Li, Dezhi
    Liu, Jie
    Zhang, Li
    Xu, Tianshu
    Chen, Junheng
    Wang, Liping
    Zhao, Qi
    VIROLOGICA SINICA, 2015, 30 (06) : 449 - 456
  • [43] Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
    Rudometov, Andrey P.
    Chikaev, Anton N.
    Rudometova, Nadezhda B.
    Antonets, Denis, V
    Lomzov, Alexander A.
    Kaplina, Olga N.
    Ilyichev, Alexander A.
    Karpenko, Larisa, I
    VACCINES, 2019, 7 (03)
  • [44] Rescue of HIV-1 Broad Neutralizing Antibody-Expressing B Cells in 2F5 VH x VL Knockin Mice Reveals Multiple Tolerance Controls
    Verkoczy, Laurent
    Chen, Yao
    Bouton-Verville, Hilary
    Zhang, Jinsong
    Diaz, Marilyn
    Hutchinson, Jennifer
    Ouyang, Ying-Bin
    Alam, S. Munir
    Holl, T. Matt
    Hwang, Kwan-Ki
    Kelsoe, Garnett
    Haynes, Barton F.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (07): : 3785 - 3797
  • [45] P19-31. Neutralizing antibodies specific for the transmembrane envelope proteins of gammaretroviruses and of HIV-1 (2F5, 4E10): comparison of their action
    M Eschricht
    U Fiebig
    R Kurth
    J Denner
    Retrovirology, 6
  • [46] The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5
    Huarte, Nerea
    Lorizate, Maier
    Maeso, Ruben
    Kunert, Renate
    Arranz, Rocio
    Valpuesta, Jose M.
    Nieva, Jose L.
    JOURNAL OF VIROLOGY, 2008, 82 (18) : 8986 - 8996
  • [47] An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
    Nelson, Josh D.
    Brunel, Florence M.
    Jensen, Richard
    Crooks, Emma T.
    Cardoso, Rosa M. F.
    Wang, Meng
    Hessell, Ann
    Wilson, Ian A.
    Binley, James M.
    Dawson, Philip E.
    Burton, Dennis R.
    Zwick, Michael B.
    JOURNAL OF VIROLOGY, 2007, 81 (08) : 4033 - 4043
  • [48] Cross-neutralizing human monoclonal anti-HIV-1 antibody 2F5:: Preparation and crystallographic analysis of the free and epitope-complexed forms of its Fab′ fragment
    Bryson, S
    Cunningham, A
    Ho, J
    Hynes, RC
    Isenman, DE
    Barber, BH
    Kunert, R
    Katinger, H
    Klein, M
    Pai, EF
    PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05): : 413 - 418
  • [49] Crystal structure of the complex between the Fab′ fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the Fab fragment of its anti-idiotypic antibody 3H6
    Bryson, Steve
    Julien, Jean-Philippe
    Isenman, David E.
    Kunert, Renate
    Katinger, Hermann
    Pai, Emil F.
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 382 (04) : 910 - 919
  • [50] Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro.: Implications for vaccine design (vol 277, pg 45811, 2002)
    Joyce, JG
    Hurni, WM
    Bogusky, MJ
    Garsky, VM
    Liang, XP
    Citron, MP
    Danzeisen, RC
    Miller, MD
    Shiver, JW
    Keller, PM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) : 5492 - 5492